

The
Gynecologic Oncology Group (GOG)
is a non-profit organization with the purpose of promoting
excellence in the quality and integrity of clinical and basic
scientific research in the field of Gynecologic malignancies.
The Group is committed to maintaining the highest standards in
clinical trials development, execution, analysis and
distribution of results. Continuous evaluation of our processes
is utilized in order to constantly improve the quality of
patient care.
To promote this mission, the GOG receives support from the
National Cancer Institute (NCI)
of the National Institutes for
Health (NIH).
Approximately 45 individual clinical trials are active at any
one time within GOG for patients with a variety of gynecologic
malignancies, including cancers that arise from the ovaries,
uterus, cervix, vagina, and vulva. General information on many
of these trials for medical professionals and the lay public can
be obtained from the
NCI PDQ clinical trials
database.